Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Blumer

Showing results (41-50 of 163) with videos related to

Pageof 17
Sort By:
Toxicology and Applied Pharmacology|August 1, 1988
Alteration of methylcholanthrene-mediated suppression of cutaneous delayed hypersensitivity by benzoflavone treatment of C57BL/6J miceD M Frank, J L Blumer
Antimicrobial Agents and Chemotherapy|September 1, 1983
Determination of ceftazidime in biological fluids by using high-pressure liquid chromatographyC M Myers, J L Blumer
Molecular Pharmacology|July 1, 1986
DNA damage in L5178YS cells following exposure to benzene metabolitesP Pellack-Walker, J L Blumer
Journal of Chromatography|March 13, 1992
Determination of platelet monoamine oxidase activity by high-performance liquid chromatography with electrochemical detectionT Ogata, C Myers, J L Blumer
The Journal of Antimicrobial Chemotherapy|July 1, 1995
The pharmacokinetics of meropenem in infants and children: a population analysisE M Parker, M Hutchison, J L Blumer
The Pediatric Infectious Disease Journal|April 17, 2001
Review of the pharmacokinetics of cefepime in childrenJ L Blumer, M D Reed, C Knupp
Pediatric Research|August 1, 1983
Prostaglandin E2 concentration in gastric secretions of critically ill, full-term, and premature infantsL R Marino, J L Blumer, T C Halpin
Pediatric Pharmacology (New York, N.Y.)|January 1, 1986
Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxicationB L Ohning, M D Reed, J L Blumer
Clinical Therapeutics|September 1, 1996
Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis mediaJ L Blumer, W P Forti, T L Summerhouse
Drug Intelligence & Clinical Pharmacy|September 1, 1984
Moxalactam therapy of serious pediatric infectionsM D Reed, S C Aronoff, J L Blumer
Pageof 17

Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Toxicology and Applied Pharmacology|August 1, 1988
Alteration of methylcholanthrene-mediated suppression of cutaneous delayed hypersensitivity by benzoflavone treatment of C57BL/6J miceD M Frank, J L Blumer
Antimicrobial Agents and Chemotherapy|September 1, 1983
Determination of ceftazidime in biological fluids by using high-pressure liquid chromatographyC M Myers, J L Blumer
Molecular Pharmacology|July 1, 1986
DNA damage in L5178YS cells following exposure to benzene metabolitesP Pellack-Walker, J L Blumer
Journal of Chromatography|March 13, 1992
Determination of platelet monoamine oxidase activity by high-performance liquid chromatography with electrochemical detectionT Ogata, C Myers, J L Blumer
The Journal of Antimicrobial Chemotherapy|July 1, 1995
The pharmacokinetics of meropenem in infants and children: a population analysisE M Parker, M Hutchison, J L Blumer
The Pediatric Infectious Disease Journal|April 17, 2001
Review of the pharmacokinetics of cefepime in childrenJ L Blumer, M D Reed, C Knupp
Pediatric Research|August 1, 1983
Prostaglandin E2 concentration in gastric secretions of critically ill, full-term, and premature infantsL R Marino, J L Blumer, T C Halpin
Pediatric Pharmacology (New York, N.Y.)|January 1, 1986
Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxicationB L Ohning, M D Reed, J L Blumer
Clinical Therapeutics|September 1, 1996
Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis mediaJ L Blumer, W P Forti, T L Summerhouse
Drug Intelligence & Clinical Pharmacy|September 1, 1984
Moxalactam therapy of serious pediatric infectionsM D Reed, S C Aronoff, J L Blumer
Pageof 17